8th Annual Perspectives in Breast Cancer

Last Modified: August 11, 2002

Share article


Conference Dates: October 17 - 18, 2002
Conference Location: Atlanta, Georgia, USA


Sponsoring Group: Imedex, Inc.

Conference Web Page URL: www.imedex.com/announcements/breast02.html

Topics Covered: Breast Cancer Biology, Screening and Diagnosis, DCIS and Early Breast Cancer, DCIS and Early Breast Cancer, Systemic Therapies, New Targeted Approaches

Conference Objectives: After successfully completing this educational program, participants should be able to:

  • Select the most appropriate techniques for screening, diagnosis, and initial evaluation of breast cancer
  • List the most important prognostic and predictive factors in breast cancer
  • Advise patients with DCIS, early stage or metastatic breast cancer on the most appropriate treatment
  • Adapt the management of their breast cancer patients in light of the latest clinical research findings
  • List the most promising future strategies for the management of breast cancer

Who Should Attend: This educational program is intended for physicians in active clinical practice who are interested and/or involved in the management of patients with breast cancer. No specialized knowledge or skills other than a general familiarity with cancer and its treatment is required for successful participation in this program.

Registration Information: Online: www.imedex.com, Fax: 770-751-7334, Telephone: 770-751-7332, Mail: Imedex, Inc. 70 Technology Drive, Alpharetta, GA 30005

Conference Fees: $225 by August 12; $325 by October 11; $425 after October 11

Continuing Education: Yes

Miscellany: Imedex USA, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Imedex USA, Inc. designates this continuing medical education activity for up to 13.5 credit hours in Category 1 of the Physician's Recognition. Each participant should claim only those hours of credit that he/she actually spent in the educational activity.


News
Participants had regular mammography; changes parallel drop in hormone therapy use after 2002

Nov 12, 2010 - Alongside a steep decline in the use of hormone therapy, incidence of invasive breast cancer and ductal carcinoma in situ fell in older women undergoing regular mammography in 2002 to 2006, according to research published online Nov. 8 in the Journal of Clinical Oncology.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More